36 Advanced sorption analyser for carbon capture research


Hiden Isochema, a leading manufacturer of sorption instrumentation, has launched the IGA ECOsorp, a ground-breaking benchtop sorption analyser tailored specifically for carbon capture research. This state-of-the-art instrument integrates advanced capabilities for co-adsorption of water and carbon dioxide across various carbon capture conditions, positioning it as an essential tool for researchers and scientists in the field.


The IGA ECOsorp combines high-resolution gravimetric water sorption with CO2 gas sorption under dynamic flow conditions, offering an economical and practical solution for evaluating the performance of candidate carbon capture sorbents in a wide range of environmental settings.


“We are thrilled to introduce the IGA ECOsorp to the scientific community,” remarked Dr Mark Roper, Sales and Marketing Director at Hiden Isochema. “This cutting-edge instrument underscores our commitment to delivering high-quality, dependable tools for advanced research. Its unique capabilities will significantly empower researchers to develop and optimise new materials for carbon capture, thereby contributing to global efforts in combating climate change.”


Key features of the IGA ECOsorp include simultaneous measurement of water and CO2 to 100%), proprietary barometric compensation technology for precise CO2


sorption, widest controllable CO2 partial pressure range (from 100 ppm flow regulation, and an advanced thermostat design ensuring long-term stability. The


instrument supports complete automation for high-resolution isothermal and extended cycling studies, facilitating detailed method development and analysis. Additionally, it offers fully programmable experimental protocols and in-situ degassing and activation capabilities with an integral heater reaching up to 350°C for sorbent regeneration.


Engineered to independently control carbon dioxide and water concentrations, the IGA ECOsorp enables accurate assessment of material performance under Direct Air Capture (DAC) conditions. It supports fully programmable measurements across temperatures ranging from 5 to 85°C, accommodating in situ degassing and regeneration at elevated temperatures.


More information online: ilmt.co/PL/bBk5 62908pr@reply-direct.com


Innovative Anti-AAV kit advances gene therapy development Gyros Protein Technologies AB has announced the launch of its Gyrolab®


Generic Anti-Adeno Associated Virus (AAV) Kit. This advanced, ready-to-use kit enables


the qualitative assessment of pre-existing binding antibodies against AAV vectors, facilitating efficient screening in both pre-clinical and clinical environments. It addresses the critical need to identify pre-existing immunity that could impact the effectiveness of AAV-based gene therapy delivery.


The kit is designed to detect total binding anti-capsid antibodies across commonly used AAV serotypes, eliminating the necessity for serotype-specific assay development. This innovation streamlines the screening process, ensuring reproducible data while minimising variability and conserving valuable drug volumes by requiring minimal quantities of viral capsids.


Optimised for integration with all Gyrolab systems, this solution extends the capabilities of the Gyrolab platform into the bioanalytical field of AAV-based gene therapies. Automation capabilities reduce variability associated with manual processes, accelerate assay development, and deliver results in just 90 minutes, thereby expediting the advancement of novel gene therapies.


Mark Vossenaar, General Manager of the Biopharmaceutical Development Division at Gyros Protein Technologies, highlighted the kit’s benefits: “The Gyrolab Generic Anti-AAV Kit represents a significant leap forward in the bioanalysis of AAV-based gene therapeutics, focusing on efficiency and time-saving. This addition to our portfolio of ready-to-use kits offers a rapid, cost-effective solution for detecting total binding antibodies, empowering informed decision-making without the need for serotype-specific assay development or extensive optimisation. It ensures convenience, reliability, and robust data for our customers, enabling precise individual stratification following pre-existing anti-AAV antibody screening.”


More information online: ilmt.co/PL/6500 62856pr@reply-direct.com


Cleanroom solutions for particle-free environments


Cleanroom technology can be used in the manufacture, storage of dust-sensitive mechanical and electronic components, packaging and wherever a particle-free environment is needed.


Spetec has extended its cleanroom offering to encompass three different cleanroom concepts. It is possible to implement solutions for the whole range of requirements, from inexpensive installations right up to top-class cleanrooms compliant with the GMP guidelines for the pharmaceuticals industry.


The cell itself is enclosed by an odourless plastic strip curtain or side panels made from acrylic or laminated glass or aluminium sandwich panels, resulting in a self-contained unit. Other optional features are also available, such as electric sliding doors or airlocks for material or personnel, which can be fitted with a mutual locking system if required.


The effective cleanroom area anywhere between 3 m² and around 350 m² can be varied by combining individual laminar flow modules of different sizes. It is even possible to integrate assembly lines or conveyors in the cleanroom cell.


The SPETEC® cleanroom cell uses H14 filters. These have a filtration efficiency of 99.995%. The filter captures at least 99.995% of all particles of a size of 0.12 μm (as per MPPS). The filtration efficiency is approx. 99.9995% for particles with a size of 0.3 μm. This laminar airflow below the flow modules means that there is no crossover with dirty air from the outside.


Using a SPETEC® cleanroom cell can, for example, reduce the particle concentration from approx. 15 million/m3 (at a size of 0.12 μm, MPPS) to approx. 1,500 particles within the unit. This corresponds to the cleanroom class 5 as per DIN ISO 5 or class 100 as per US Federal Standard 209E.


It is also possible to meet the requirements of ISO classes 6 through 9 (DIN ISO 14644-1) and classes A through D of the GMP standard. Depending on the precise requirements, SPETEC® cleanroom cells can be adapted to meet the customers’ needs.


More information online: ilmt.co/PL/pwyB 62882pr@reply-direct.com


New programmable hot plate with precise temperature control


Torrey Pines Scientific, Inc. announces its new EchoTherm™ Programmable Digital Stirring Hot Plate for use in chemical, pharmaceutical, environmental, biochemical, and other laboratories where reproducible, accurate chemical reaction control and sample preparation are essential.


With the user-friendly EchoTherm™ Model HS40, programming is done through the front panel membrane switch and full-function custom liquid crystal display. The unit can store 10 programs in memory, each with up to 10 steps, where each step is a temperature, temperature ramp rate, stirring speed, and time. Each program can be set to repeat automatically from 1 to 98 times, or infinitely if desired. All programs are stored electronically.


Heater plates are 8” (20.3 cm) x 8” (20.3 cm) white, solid ceramic glass for excellent chemical resistance and quick heating. The plate surface can be heated from ambient to 450°C in less than 3 minutes. Plate surface temperature or solution temperature can be controlled directly to within 1°C of the target. Accuracy is 1% of the reading using platinum RTD circuitry. The units are supplied with temperature calibration certificates traceable to NIST.


Stirring speed ranges from 100 to 1500 rpm and is controlled by an optical coupler to within 10 rpm. A countdown timer with alarm, user-settable Auto-Off, and an RS232 I/O port are standard. Various sample probes are available as accessories. The Model HS40 is available in 100, 115, and 230 VAC, 50/60 Hz models. All units are ETL, CSA, and CE certified.


More information online: ilmt.co/PL/RX9L 62833pr@reply-direct.com


LAB ASIA - AUGUST 2024


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48